Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.360
-0.020 (-1.45%)
Mar 9, 2026, 3:27 PM EDT - Market open
Jasper Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 38 | 321 | 88 | 22 | 389 | 125 | |
| Market Cap Growth | -58.82% | 264.33% | 294.73% | -94.26% | 210.66% | - | |
| Enterprise Value | -11 | 230 | -13 | -25 | 291 | - | |
| Last Close Price | 1.38 | 21.38 | 7.89 | 4.83 | 78.50 | 100.10 | |
| PB Ratio | 3.34 | 5.20 | 1.12 | 0.62 | 5.59 | 14.37 | |
| P/TBV Ratio | 3.34 | 5.20 | 1.12 | 0.62 | 5.59 | - | |
| Debt / Equity Ratio | 0.15 | 0.03 | 0.04 | 0.10 | 0.04 | 0.19 | |
| Net Debt / Equity Ratio | -4.25 | -1.13 | -1.07 | -0.96 | -1.18 | -2.09 | |
| Net Debt / EBITDA Ratio | 0.54 | 0.93 | 1.24 | 0.69 | 2.24 | - | |
| Net Debt / FCF Ratio | 0.64 | 1.11 | 1.61 | 0.75 | 2.27 | 1.00 | |
| Quick Ratio | 2.42 | 4.70 | 7.04 | 5.54 | 10.63 | 5.09 | |
| Current Ratio | 2.59 | 4.97 | 7.19 | 5.91 | 10.95 | 5.16 | |
| Return on Equity (ROE) | -191.12% | -101.73% | -112.67% | -71.44% | -78.33% | -212.46% | |
| Return on Assets (ROA) | -72.92% | -54.52% | -60.09% | -45.06% | -39.35% | -51.13% | |
| Return on Capital Employed (ROCE) | -251.20% | -117.90% | -83.40% | -124.00% | -43.00% | -106.90% | |
| Earnings Yield | -235.70% | -22.22% | -73.23% | -168.98% | -7.88% | -25.31% | |
| FCF Yield | -198.17% | -19.69% | -59.45% | -208.21% | -9.29% | -14.60% | |
| Buyback Yield / Dilution | -15.70% | -39.72% | -186.15% | -220.19% | -558.67% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.